Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Jobin

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
L'Union Medicale Du Canada|February 1, 1978
[Venous thromboemboli]J Hirsh, F Jobin, A G Turpie
Blood|November 26, 1999
Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombastheniaM C Poon, C Demers, F Jobin, et al.
L'Union Medicale Du Canada|October 1, 1978
[Hodgkin's disease (study of 99 cases occurring during a 10-year period)]J M Delage, A Barry, C Petitclerc, et al.
Thrombosis and Haemostasis|April 2, 1992
Prevention of deep vein thrombosis after major knee surgery--a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placeboJ R Leclerc, W H Geerts, L Desjardins, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
L'Union Medicale Du Canada|February 1, 1978
[Venous thromboemboli]J Hirsh, F Jobin, A G Turpie
Blood|November 26, 1999
Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombastheniaM C Poon, C Demers, F Jobin, et al.
L'Union Medicale Du Canada|October 1, 1978
[Hodgkin's disease (study of 99 cases occurring during a 10-year period)]J M Delage, A Barry, C Petitclerc, et al.
Thrombosis and Haemostasis|April 2, 1992
Prevention of deep vein thrombosis after major knee surgery--a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placeboJ R Leclerc, W H Geerts, L Desjardins, et al.
Pageof 3